Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Reuter

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
Journal of Neurology|June 28, 2018
Brain imaging in pregnant women with acute headacheBianca Raffaelli, Lars Neeb, Heike Israel-Willner, et al.
Nature Medicine|February 1, 2002
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine modelHayrunnisa Bolay, Uwe Reuter, Andrew K Dunn, et al.
Journal of Clinical Medicine|July 27, 2024
Translation of Multidimensional Health Locus of Control Scales, Form C in Patients with HeadacheLuise Bartsch, Nadja Fiebig, Sebastian Strauß, et al.
Cephalalgia : an International Journal of Headache|September 28, 2021
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort studyBianca Raffaelli, Maria Terhart, Lucas Hendrik Overeem, et al.
The Journal of Headache and Pain|May 25, 2019
Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine preventionSimona Sacco, Lars Bendtsen, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache|September 22, 2010
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trialMichel D Ferrari, Markus Färkkilä, Uwe Reuter, et al.
The Journal of Headache and Pain|October 26, 2021
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugsFenne Vandervorst, Laura Van Deun, Annelies Van Dycke, et al.
Headache|May 12, 2026
Efficacy of a multidisciplinary 5-day headache day-clinic program: A prospective quasi-experimental pre-post study in primary headache disordersNadja Fiebig, Luise Bartsch, Christine Klötzer, et al.
Headache|February 4, 2015
No microstructural white matter alterations in chronic and episodic migraineurs: a case-control diffusion tensor magnetic resonance imaging studyLars Neeb, Kaili Bastian, Kersten Villringer, et al.
Cephalalgia : an International Journal of Headache|October 21, 2010
Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramateJean Schoenen, Uwe Reuter, Hans-Christoph Diener, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Journal of Neurology|June 28, 2018
Brain imaging in pregnant women with acute headacheBianca Raffaelli, Lars Neeb, Heike Israel-Willner, et al.
Nature Medicine|February 1, 2002
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine modelHayrunnisa Bolay, Uwe Reuter, Andrew K Dunn, et al.
Journal of Clinical Medicine|July 27, 2024
Translation of Multidimensional Health Locus of Control Scales, Form C in Patients with HeadacheLuise Bartsch, Nadja Fiebig, Sebastian Strauß, et al.
Cephalalgia : an International Journal of Headache|September 28, 2021
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort studyBianca Raffaelli, Maria Terhart, Lucas Hendrik Overeem, et al.
The Journal of Headache and Pain|May 25, 2019
Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine preventionSimona Sacco, Lars Bendtsen, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache|September 22, 2010
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trialMichel D Ferrari, Markus Färkkilä, Uwe Reuter, et al.
The Journal of Headache and Pain|October 26, 2021
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugsFenne Vandervorst, Laura Van Deun, Annelies Van Dycke, et al.
Headache|May 12, 2026
Efficacy of a multidisciplinary 5-day headache day-clinic program: A prospective quasi-experimental pre-post study in primary headache disordersNadja Fiebig, Luise Bartsch, Christine Klötzer, et al.
Headache|February 4, 2015
No microstructural white matter alterations in chronic and episodic migraineurs: a case-control diffusion tensor magnetic resonance imaging studyLars Neeb, Kaili Bastian, Kersten Villringer, et al.
Cephalalgia : an International Journal of Headache|October 21, 2010
Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramateJean Schoenen, Uwe Reuter, Hans-Christoph Diener, et al.
Pageof 18